The University of Chicago Header Logo

Connection

Richard Schilsky to Tumor Burden

Back to Details
This is a "connection" page, showing publications Richard Schilsky has written about Tumor Burden.
Richard Schilsky
Connection Strength
0.180
Tumor Burden
  1. Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. J Clin Oncol. 2021 08 01; 39(22):2443-2451.
    View in: PubMed
    Score: 0.180
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.